Valion Bio (VBIO) executive compensation, 2026 proxy

Michael Handley, Chief Executive Officer and Director; Former Chief Operating Officer, was paid $590,694 in 2025.

Filed
April 30, 2026
Annual meeting
May 28, 2026
Pay year
2025
Named executives
3
CEO total pay
$590,6942025
CEO pay in equity
75%$441,105 in awards
CEO Salary
$261,250Michael Handley
Former CEO Salary
$300,000Jennifer Ernst
CFO Salary
$116,364Lisa Wolf
CEO Stock Awards
$305,655Michael Handley

How Handley was paid

$590,694 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Jennifer ErnstFormer Chief Executive Officer and Director$396,767
Michael HandleyChief Executive Officer and Director; Former Chief Operating Officer$590,694
Lisa WolfChief Financial Officer$333,977

What changed and why

  • $591KMichael Handley received total compensation of $590,694 for fiscal 2025 in his role as CEO and former COO.
  • $397KJennifer Ernst received total compensation of $396,767 for fiscal 2025 prior to her resignation as CEO.
  • $334KLisa Wolf received total compensation of $333,977 for fiscal 2025 after transitioning to permanent Chief Financial Officer.
  • $325KJennifer Ernst entered into an executive employment agreement providing an annual base salary of $325,000.
  • Michael Handley received an inducement grant of 600,000 restricted stock units outside of the 2021 Plan.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.